Abstract
Although attempts to enhance athletic performance are probably much older, the word “doping” was first mentioned in 1889 in an English dictionary. It described originally a mixed remedy containing opium, which was used to “dope” horses. “Dope” was a spirit prepared from the residues of grapes, which Zulu warriors used as a “stimulant” at fights and religious procedures and which also reportedly was called “doop” in Afrikaans or Dutch. Later, the meaning of “dope” was extended in a broader sense to other beverages with stimulating properties. The expression was introduced into English Turf Sport about 1900 for illegal drugging of racehorses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abourashed EA, El-Alfy AT, Khan IA et al (2003) Ephedra in perspective – a current review. Phytother Res 17:703–712
Aguilera R, Becchi M, Casabianca H, Hatton C, Catlin DH, Starcevic B, Pope HG Jr (1996) Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 31:169
Ayotte C (2006) Significance of 19-norandrosterone in athletes’ urine samples. Br J Sports Med 40(Suppl 1):125
Ayotte (2009) Detecting the administration of endogenous anabolic androgenic steroids. In: Thieme D, Hemmersbach P (eds) Doping in Sports, Handbook of Experimental Pharmacology 195, Springer, Heidelberg
Badyshtov BA, Losev AS, Makhnycheva AL, Barchukov VG, Sytnik SI, Pastushenkov VA, Kolotilinskaia NV, Mironov SA, Morozov IS, Seredenin SB (1995) Study of heat-protective effects of bromantane at various levels of overheating. Vopr Med Khim 41:54
Becchi M, Aguilera R, Farizon Y, Flament MM, Casabianca H, James P (1994) Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 8:304
Beckett AH (1992) Clenbuterol and sport. Lancet 340:1165
Beckett AH, Cowan DA (1979) Misuse of drugs in sport. Br J Sports Med 2:185
Beckett AH, Tucker GT, Moffat AC (1967) Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. J Pharm Pharmacol 19:273
Berendonk B (1992) Doping – von der Forschung zum Betrug. Rowohlt Hamburg, ISBN 3-499186-77-2
Blickensdörfer H (1972) Der Tag, an dem Tom Simpson starb (The day when Tom Simpson died). In: Acker H (ed) Rekorde aus der Retorte (Records from the retort). Deutsche Verlagsanstalt, Stuttgart, p 104
Breidbach A, Catlin DH (2001) RSR13, a potential athletic performance enhancement agent: Detection in urine by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 15:2379
Brooks RV, Firth RG, Sumner NA (1975) Detection of anabolic steroids by radioimmunoassay. Br J Sports Med 9:89
Brooks RV, Jeremiah G, Webb WA, Wheeler M (1979) Detection of anabolic steroid administration to athletes. J Steroid Biochemy 11:913
Bumat P, Payen A, Le Brumant-Payen C, Hugon M, Ceppa F (1997) Bromantan, a new doping agent. Lancet 350:963
Burstin S (1963) La Lucha contra el Dopage. Revista de Derecho Sportiva, Buenos Aires 3/8–9:583
Bux R, Zedler B, Schmidt P, Parzeller M (2008) Sudden unexpected death associated with sports. Frequency in autopsies between 1972 and 2007 (in German). Rechtsmedizin 18(3):155–160
Catlin DH (1987) Detection of drug use by athletes. In: Strauss RH (ed) Drugs and performance in sports. W.B. Saunders Co, Philadelphia, p 104
Catlin DH (1999) Overview and drug monographs. In: International Olympic Committee Medical Commission Doping – An IOC White Paper, IOC Lausanne
Catlin DH, Breidbach A, Elliott S, Glaspy J (2002) Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clin Chem 48:2057
Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK (2004) Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18:1245
Chinery S (1983) Anabolic steroids and bodybuilding. SMS Publishing, Toms River, NJ, p 41
Clasing D, Donike M, Klümper A (1974) Dopingkontrollen bei den Spielen der XX. Olympiade München 1972. Leistungssport 4:130 and 4:303
Council of Europe (1989) Anti-doping convention (ETS No. 135) Council of Europe Strasbourg, ISBN 92-871-2765-4
Deventer K, van Eenoo P, Delbeke FT (2006) Detection of hydroxyethylstarch (HES) in human urine by liquid chromatography–mass spectrometry. J Chrom B: Anal Technol Biomed Life Sci 834:217
Dirix A (1984, 1992) Medical Guides International Olympic Committee Medical Commission, Lausanne
Dirix A (1986) The doping problem at the Tokyo and Mexico City Olympic Games. J Sports Med Phys Fitness 6:183
Dirix A, Sturbois X (1998) The first thirty years of the International Olympic Committee Medical Commission 1967–1997. International Olympic Committee (IOC Booklet Series “History and Facts”), Lausanne
Donike M, Kaiser CH (1971) Moderne methoden der dopinganalyse. Sportarzt und Sportmedizin 3:57
Donike M, Clasing D, Klümper A (1974) Dopingkontrollen bei den Spielen der XX. Olympiade München 1972 part 2. Leistungssport (Berlin) 4:192
Donike M, Kaiser CM, Klehr HL (1976) Die Dopingkontrollen in Montreal. Bundesinstitut für Sportwissenschaft Köln, Selbstverlag
Donike M, Bärwald KR, Klostermann K, Schänzer W, Zimmermann J (1983) Nachweis von exogenem Testosteron (Detection of endogenous testosterone). In: Heck H (ed) Sport: Leistung und Gesund- heit, Kongressband Deutscher Sportärztekongress 1982, Deutscher Ärzte Verlag Köln, p 293
Donike M et al (1996) Blut und/oder Urin zur Dopingkontrolle. Bundesinstitut für Sportwissenschaft, vol 86, Verlag Karl Schorndorf Köln, ISBN 3-7780-8861-0
Duchaine D (1989) Underground steroid handbook. HLR Technical Books, Venice, CA 90291
Eckart WU (2003) Die grüne Muse. Süddeutsche Ztg. 96/ 26:14
Edeleanu L (1887) Über einige Derivate der Phenylmethacrylsaure und der henylisobuttersaure. Ber Deutsch Chem Ges 20:616
Fahey T, Fritz B (1991) Steroid alternative handbook. Sports Science Publications, San José, CA, USA, p 29
Fainaru M, Williams L (2003) Barry bonds: anatomy of a scandal. San Francisco Chronicle, http://www.seattlepi.com/baseball/153951_steriods25.html 05 April 2009
Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1–14
Franke WW (1997) Hormonal doping and androgenizing of athletes: a secret program of the German Democratic Republic Government. Clin Chem 43/7:1262–1279
Freeman ER, Bloom DA, McGuire EJ (2001) A brief history of testosterone. J Urol 165:371–373
Goldmann B (1984) Death in the locker room. Icarus Press, South Bend
Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG (2003) Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88:333
Grekhova TV, Gainetdinov RR, Sotnikova TD, Krasnykh LM, Kudrin VS, Sergeeva SA, Morozov IS (1995) The effect of bromantane, a new immunostimulant with psychostimulating action, on release and metabolism of dopamine in the dorsal striatum of freely moving rats: a microdialysis study. Biull Eksp Biol Med 119:302
Hanley DF (1983) Drogen und Drogenmissbrauch (drugs and drug abuse). In: Strauss R (ed) Sportmedizin und Leistungsphysiologie, Enke Verlag Stuttgart, p 402
Hemmersbach P (2008) History of mass spectrometry at the Olympic Games. J Mass Spectrom 43:839–853
Hemmersbach P, de la Torre R (1996) Stimulants, narcotics and ß-blockers: 25 years of development in analytical techniques for doping control. J Chrom B 687:221
Horning S, Donike M (1994) High-resolution GC/MS. In: Donike M et al (eds) Recent advances in doping analysis – proceedings of the 11th cologne workshop, 7–12 March 1993. Sport und Buch Strauss, Köln, p 155
Horning S, Geyer H, Machnik M, Schänzer W, Hilkert A, Oesselmann J (1996) Detection of exogenous testosterone by 13C/12C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis, vol 4. Sport und Buch Strauss, Köln, p 275
Houlihan B (1999) Dying to win. Doping in sport and the development of anti-doping policy. Council of Europe, Strasbourg, ISBN 92-871-3589-4
International Olympic Committee (IOC) Medical Commission (1972) Doping (published in cooperation with the International Organizing Committee for the Olympic Games in Munich and in Sapporo 1972), IOC Lausanne
Jasuja R, Catlin DH, Miller A, Chang YC, Herbst KL, Starcevic B, Artaza JN, Singh R, Datta G, SarkissianA CC, Baker M, Bhasin S (2005) Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes musde accretion in orchidectomized male rats. Endocrinology 146:4472
Kim S, Park JH, Myung SW, Lho DS (1999) Determination of carphedon in human urine by solid-phase microextraction using capillary gas chromatography with nitrogen–phosphorus detection. The Analyst 124:1559
Kohler M, Thevis M, Schänzer W, Püschel K (2008) Damage to health and fatalities from doping (in German). Rechtsmedizin 18(3):177–182
Kudrin VS, Sergeeva SA, Krasnykh LM, Miroshnichenko II, Grekhova TV, Gainetdinov RR (1995) The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain. Eksp Klin Farmakol 58:8
Lasne F (2001) Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J lmmunol Methods 53:125
Lasne F, de Ceaurriz J (2000) Recombinant erythropoietin in urine. Nature 405:635
Lasne F, Martin L, Crepin N, de Ceaurriz J (2002) Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 311:119
Lüderwald S, Zinka B, Thieme D, Eisenmenger W (2008) Misuse of anabolic androgenic steroids. Fatal cases in recreational bodybuilding. Rechtsmedizin 18(3):183–188
Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ (1987a) The effect of the anabolic agent clenbuterol on overloaded rat skeletal muscle. Biosci Rep 7:143
Maltin CA, Hay SM, Delday MI, Smith FG, Lobley GE, Reeds PJ (1987b) Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci Rep 7:525
Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W (2008) Factors influencing the steroid profile in doping controlanalysis. J Mass Spectrom. 43:7. doi:10.1002/jms.1457
Maurer HH (2006) Hyphenated mass spectrometric techniques–indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom 41:1399
McLaren R (2001) International Sports law perspective: introducing the court for arbitration for sport – the ad-hoc division at the Olympic Games. Marquette Sports Law Rev 12:515
Merode, Prince A de (1999) Introduction and background in: International Olympic Committee Medical Commission Doping – An IOC White Paper, IOC Lausanne
Michna H (ed) Biomedical side effects of doping. Scientific Reports of the Federal Institute of Sport Sciences Bonn, vol 23, Sport und Buch Strauss Köln, ISBN 3-89001-363-5
Müller RK (2000) Doping relevance and doping definition – suggested extension of the IOC list of examples to the banned groups of substances. In: Biology of Sport, vol 17/2, pp 73–80
Müller RK (2001) Am horizont: gendoping im sport? In: Güldenpfennig S, Krickow D (eds) Jahrbuch des Deutschen Olympischen Instituts, Berlin, ISBN 3-9807747-1-6, pp 249–260
Müller RK, Müller-Platz (2001) Aggression and anabolic steroid hormones. Do anabolic androgenic steroids enhance aggressiveness? In: Michna H (ed) Biomedical side effects of doping. Scientific Reports of the Federal Institute of Sport Sciences Bonn, vol 23. Sport und Buch Strauss, Köln, ISBN 3-89001-363-5, pp 107–113
Müller RK, Thieme D (eds) (2000) Progress in hair analysis for illegal drugs. Scientific reports and materials of the Federal Institute of Sport Sciences, Bonn. Sport und Buch Strauss, Köln, ISBN 3-89001-335-X
Müller RK, Grosse J, Thieme D, Lang R (1999) Carphedon – Identifikation einer neuen Designerdroge. Rechtsmedizin 9:215
Müller RK, Grosse J, Thieme D, Preiss R (2000) Banned agents and related compounds – how many? In: SchänzerW, Geyer H, Gotzmann A, Marek-Engelke U (eds) Recent advances in doping analysis 7. Sport und Buch Strauss, Köln, ISBN-3-89001-335-X
Müller RK, Grosse J, Wahl A (2003) Doping. In: Madea B, Brinkmann B (eds) Handbuch der gerichtlichen Medizin (Manual of Forensic Medicine). Springer, Berlin, pp 188–198
Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, Martin DT, Trout GJ, Hahn AG (2000) A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85:564
Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ, Xie M (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86:128
Peters C, Schulz T, Michna H (2001) Biomedical side effects of doping. Bundesinstitut für Sportwissenschaft Köln, Sport und Buch Strauss, ISBN 3-89001-363-5
Pfleger K, Maurer HH, Weber A (2000) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites, Part 4. Wiley-VCH Weinheim
Pini M-C (1964) Estudo critico da dopago, Sao Paulo
Pozo OJ, Deventer K, Van Eenoo P, Delbeke F (2008) Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography–electrospray-tandem mass spectrometry. Analyt Chem 80:1709
Prokop L (1957) Leistungssteigerung durch Placebos (Performance enhancement by placebos), XI. Congres International de Medicine Sportive, Luxembourg
Prokop L (1970) The struggle against doping and its history. J Sports Med Phys Fitness 10:45
Prokop L (1972) Zur Geschichte des Dopings (On the history of doping). In: Acker H (ed) Rekorde aus der Retorte (records from the retort), Deutsche Verlagsanstalt Stuttgart, p 22
Prokop L (2002) Lecture on the history of doping. Antidoping Laboratory, Austrian Research Center Seibersdorf
Raschka C (2008) Fatal doping cases in sport. A historical review (in German). Rechtsmedizin 18(3):173–176
Sachs H, Kintz P (2000) Consensus if the Society of Hair Testing on hair testing for doping agents. Forensic Sci Int 107:3
Sachs H, Möller RM (1989) Detection of drugs in hair by GC/MS. Fresenius Z Anal Chem 334:713
Shackleton CHL, Phillips A, Chang T, Li Y (1997) Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62:379
Spitzer G (1989) Doping in der DDR. Bundesinstitut für Sportwissenschaft, Köln, Sport und Buch Strauss Bonn, ISBN 3-89001-315-5
Spitzer G (2005a) Sicherungsvorgang Sport – Das Ministerium für Staatssicherheit und der DDR-Spitzensport. Bundesinstitut für Sportwissenschaft Bonn, Verlag Hofmann, Schorndorf, ISBN 3-7780-8971-4
Spitzer G (2005b) Schon Hitler nahm Testosteron. http://www.faz.net/s/Rub906784803A9943C4A3399622FC846D0D/Doc~E15C38CBE153048898F5CB707B0DC80D1~ATpl~Ecommon~Scontent.html Cited 10 April 2009
Spitzer G, Teichler HJ, Reinartz K (1999) Das Leistungssportsystem der DDR in den 80er Jahren und im Prozess der Wende. Bundesinstitut für Sportwissenschaft Bonn, Verlag Hofmann, Schorndorf, ISBN 3-7780-8961-7
Teichler HJ (2003) Sport in der DDR – Eigensinn, Konflikte, Trends. Bundesinstitut für Sportwissenschaft Bonn, Sport und Buch Strauss Köln, ISBN 3-89001-387-2
Thevis M, Schänzer W (2005) Mass spectrometry in doping control analysis. Curr Org Chem 9:825
Thevis M, Schänzer W (2007) Mass spectrometry in sports drug testing: structure characterization and analytical assays. Mass Spectrom Rev 26:79
Thevis M, Opfermann G, Schänzer W (2000) Detection of the plasma volume expander hydroxyethyl starch in human urine. J Chromatogr B 744:345
Thevis M, Geyer H, Mareck U, Schänzer W (2005) Screening for unknown synthetic steroids in human urine by liquid chromatography–tandem mass spectrometry. J Mass Spectrom. 40:955
Todd J, Todd T (2001) Significant events in the history of drug testing and the Olympic movement: 1960–1999. In: Wilson W, Derse E (eds) Doping in elite sport – The politics of drugs in the Olympic Movement. Human Kinetics Publishers
US Food and Drug Administration. Dietary Supplement and health education act. http://www.fda.gov/opacom/laws/ dshea.html, Cited 05 April 2008
UNESCO (2005) International Convention against Doping in Sport 2005, http://portal.unesco.org/en/ev.php-URL_ID=31037&URL_DO&DO_TOPIC&URL_SECTION=201.html. Cited 24 September 2009
Venerando A (1963) Pathologia del Doping e mezzi di controllo. Medicine dello Sport, Roma, p 3
WADA (World Anti-Doping Agency) (2008a) The 2009 Prohibited List. http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf. Cited 10 April 2009
WADA (World Anti-Doping Agency) (2008b) International Standard for laboratories, Version 5.0, http://www.wada-ama.org/rtecontent/ document/lab-08_V_05.pdf
WADA (World Anti-Doping Agency) (2008c) WADA-accredited laboratories. http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=333, Cited 09 April 2009
WADA (World Anti-Doping Agency) (2008d) Independent observer report. http://www.wada-ama.org/rtecontent/document/sydney_ io_report.pdf
WADA (World Anti-Doping Agency) (2009a) A brief history of anti-doping. http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=312, Cited 10 April 2009
WADA (World Anti-Doping Agency) (2009b) World Anti-Doping Code, http://www.wada-ama.org/rtecontent/document/code_v2009_En.pdf. Cited 24 September 2009
Wadler GI, Hainline B (1989) Drugs and the athlete. FA Davis Company, Philadelphia, ISBN 0-8036-9008-8
Westwood S, Noble B, Moule C (1999) Synthesis and characterisation of steroid metabolites for use as analytical reference materials. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis – proceedings of the 17th cologne workshop, 14–19 March 1999, vol 7. Sport und Buch Strauss Köln, p 181
Wright JE, Cowart VS (1990) Anabolic steroids: altered states. Cooper Publishing Group, Traverse City, USA
Yates D, Wolff B (1993) Blood and guts – The ultimate approach to building maximum muscle mass (German translation 1995: Blut und Schweiss, Sport Verlag Ingenohl, Heilbronn)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Appendix 1 Historical Definitions of Doping
1933 Beckmanns Sport Lexikon
Doping, the use of stimulating (performance enhancing) agents, which shall push the atlete beyond his/her normal limits of performance.
Used for this purpose are:
Adrenalin, extracts of testes, caffeine, digitalis, strychnine, camphor, nicotine, cocaine, colanine, heroin, morphine, arsenic, phosphorous, calcium, alcohol etc.
The application of doping agents is rejected for reasons of sports ethics and health and is sanctioned in many sport disciplines by dismissal and sanctions.
1952 Association of German Sport Physicians (Deutscher Sportärztebund)
The intake of any pharmaceutical – regardless its activity – with the intention to enhance performance during a competition is considered as doping.
1952 Keysers Sportlexikon
Doping: Administration of stimulating agents for the enhancement of performance in sport. Application before or during the competition causes disqualification.
1956 Lexikon des Sportes (Dictionary of Sport)
Doping: Attempts by artificial stimulants of any kind, to enhance the performance of the body beyond the natural limits.
1963 Council of Europe (Madrid)
If a necessary medical treatment carried out by any means, which by its nature is capable to enhance physical performance beyond the normal level, this is considered as doping and excludes the capability to compete.
1963 Council of Europe, Committee of General (Out-of-school) Education
Doping is the administration or the use of xenobiotic substances in each form and on each way or of physiological substances in abnormal form or by abnormal ways to healthy persons with the only aim of artificial and unfair enhancement of performance for competition. In addition, various psychological measures for performance enhancement of the athlete have to be considered as doping.
1965 Belgian Law
It is the intention of this Law that doping is considered as the use of substances or the application of methods for the artificial enhancement of performance of an athlete, who participates in a competition or prepares for a competition, if the use can be harmful for his physical or mental integrity.
The Anti-Doping Committee recommends that the Legislative should prepare such a list of substances and methods, including an adequate declaration of the prohibited doses of these substances.
1970 German Sports League (Deutscher Sportbund)
Doping is the attempt to obtain an increase of performance of athletes for competition by nonphysiological substances. Doping substances as defined by these Guidelines are phenylethylamine derivatives (strong central stimulants or “Weckamines”, ephedrines, adrenaline derivatives), narcotics, analeptics (camphor- and strychnine derivatives), sedatives, psychopharmaceuticals and alcohol.
1971 Medical Commission of the International Olympic Committee:
All substances, also if applied for therapeutic purposes, which influence performance by their composition or dosage, are doping agents, including in particular
-
1.
Sympathomimetic amines (e.g. amphetamines, ephedrines, etc.)
-
2.
Central stimulants (e.g. strychnine, analeptics, etc.)
-
3.
Narcotic analgesics (e.g. morphine, methadone, etc.)
1971 German Track and Field Association (Deutscher Leichtathletik-Verband, DLV)
“Each athlete is prohibited to take part in a competition, if he/she is under the influence of pharmaceuticals on the prohibited list. The proof of doping is obtained by qualitative detection. Time, dosage and potential of the agent are irrelevant.”
1976 International Olympic Committee
A definition of doping is not introduced.
Doping comprises the application of the substances on the following list. This list contains 76 different agents.
-
1.
Psychomotoric stimulants: amphetamines and derivatives. Sympathomimetic amines: ephedrine and derivatives. Central nervous stimulating substances: analeptics, strychnine
-
2.
Narcotics and analgesics: morphine and derivatives
-
3.
Vasodilatators: nitrites
-
4.
Anabolic steroides
1977 German Association of Sport Physicians (Deutscher Sportärztebund)
-
1.
Doping is the attempt at unphysiological enhancement of performance of an athlete by application (intake, injection or administration) of a doping substance by the athlete or an assisting person (e.g. team leader, coach, physician, nurse or physiotherapist) prior to a competition and, for the anabolic hormones, also during training.
-
2.
Doping substances according to these guidelines are in particular: Phenylethylamine derivatives (“Weckamines”), ephedrines, adrenaline derivatives, narcotics, analeptics (camphor and strychnine derivatives) and anabolic hormones. In specific sports, additional substances can be prohibited as doping agents (e.g. alcohol, sedatives, psychopharmaceuticals).
1978 German Association of Sport Physicians
Doping is the use of substances from the prohibited classes of agents:
-
(a)
Psychomotoric stimulants
-
(b)
Sympathomimetic amines
-
(c)
Various stimulants of the Central Nervous System
-
(d)
Narcotis and analgesics
-
(e)
Anabolic steroids
1986 German Association of Sport Physicians
Doping is the use of substances belonging to the prohibited classes of agents, and the application of non-permitted measures like blood doping.
Five classes of substances are defined as doping agents:
-
1.
Psychomotoric substances (stimulants)
-
2.
Narcotics
-
3.
Anabolic steroids
-
4.
Beta-receptor blockers
-
5.
Diuretics
1988 International Olympic Committee
Doping is the use of substances from the prohibited classes of agents and the use of prohibited methods.
List of prohibited classes of substances and methods
-
I.
Prohibited classes of substances
-
A.
Stimulants
-
B.
Narcotics
-
C.
Anabolic steroids
-
D.
Beta-receptor blockers
-
E.
Diuretics
-
A.
-
II.
Prohibited methods
-
A.
Blood doping
-
B.
Pharmacological, chemical and physical manipulation
-
A.
-
III.
Substances, permitted with certain restrictions
-
A.
Alcohol
-
B.
Local aneasthetics
-
C.
Corticosteroids
-
A.
1989 Anti-Doping Convention of the Council of Europe
According to this Convention are defined
“Doping in sport” the administration to or the use of pharmacological doping agents or of doping methods by athletes.
-
(a)
Pharmacological doping agents or doping methods according to paragraph 2 are those doping agents or doping methods which have been prohibited by the respective international sport organisations and are included in lists, which according to article II.1b. are confirmed by the Monitoring Group,
-
(b)
“Athletes” are those persons who participate regularly in organised sporting activities.
Until the date when a list with the prohibited doping agents and methods has been confirmed by the Monitoring Group according to Article II.I.b., the list of agents and methods attached to this Convention is valid as List of Agents and Methods.
Doping in this sense means each attempt to enhance performance by means, which normally are not administrated to the organism, whereby the intention of stimulation is essential and the manner of administration is irrelevant.
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Müller, R.K. (2010). History of Doping and Doping Control. In: Thieme, D., Hemmersbach, P. (eds) Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacology, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79088-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-79088-4_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79087-7
Online ISBN: 978-3-540-79088-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)